IRADIMED CORPORATION Resolves Warning Letter Related to Its Infusion Pump System
WINTER SPRINGS, Fla., Oct. 08, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving all issues cited in the August 2014 warning letter. “The …